 Turning Point Brands Inc NYSE: TPB stated that the Food and Drug Administration FDA had rescinded its September 14 Marketing Denial Order MDO for certain of its vapor products with pending Premarket Tobacco Product Applications MTAs under review. All of TPBs proprietary vapor products, including its Solace branded e-liquids, will continue to be marketed while they remain under review. 